NBY: NovaBay Pharmaceuticals Inc. Cash on Hand per Share

Corporate emblem and logo of NovaBay Pharmaceuticals, Inc. (NBY)

The ophthalmology sector relies on third-party logistics providers to optimize drug delivery. NovaBay Pharmaceuticals (NBY) is expanding its staff of chemists and specialized managers through a high-bonus system. Profits are driven by online sales of eyelid hygiene products and physician loyalty. The historical cash per share level reflects liquidity trends, with the metric remaining around 0.11.

NovaBay (NBY) - Cash Funds per Share from 07/04/2022 to 04/18/2026

Comprehensive metric breakdowns and analytics for NovaBay (NBY)

Comprehensive company analysis:NovaBay Pharmaceuticals Inc. - NBY
Flagship merchandise of NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals (NBY) operates under intense competition with ophthalmology giants while maintaining patent protection. This metric is calculated by dividing the total volume of liquid assets by the number of shares outstanding. It determines the real value of the physical cash reserve available per share of capital. This indicator serves as a measure of financial autonomy and the rate of resource depletion. The quarterly dynamics of cash per share allow for an assessment of the business's resilience to market pressure.